Early booking enables the initiation of prenatal fetal and maternal screening and the provision of health advice on life-style issues during pregnancy, such as healthy nutrition, exercise, alcohol and smoking cessation amongst others.
Maternal screening should lead to appropriate treatment of the mother and identification and treatment of infected children, reducing the number of people at risk for progression to serious disease and further vertical transmission.
Other successful examples of secondary prevention are anti-syphilis and anti-HIV programs which unite maternal screening and indicated treatments.
The purpose of this study was to determine the ability of uterine artery Doppler and placental ultrasound to identify adverse clinical outcomes attributable to severe placental dysfunction in women with second-trimester unexplained elevated maternal serum screening of alpha-fetoprotein and human chorionic gonadotropin.
We included only singleton gestations in the study because conventions for assigning gestational hCG to survivors of multiple gestations have not been set, maternal serum screening of multiple gestations appears much less common than for singleton gestations (53% compared to 65%), and sex-specific selection in utero among twins appears different than that among singletons (Catalano et al. 2009a).
Findings will enhance our understanding of the burden of AVF and UTI in rural Bangladesh, the impact of a maternal screening-treatment program for genitourinary tract infections on perinatal health, and help formulate public health recommendations for infection screening in pregnancy in low-resource settings.
Our results show synergistic effects based on overall maternal exposures and screening of expectant mothers at high-risk of birth defects in a high-risk area.
Assessment of maternal health and effective screening of child development may increase detection of children at high risk who would benefit from early intervention.
Currently, the routine non-invasive prenatal testing (NIPT) involves the biochemical screening of maternal serum biomarkers (PAPP-A and free - βhCG) at 9 14 wks of gestation as well the measurement of fetal NT.
Historically, the implicit endorsement of a technology under FDA regulation has led to drastic consequences on uptake; for example, it was only following FDA approval of alpha-fetoprotein screening of maternal serum that American Congress of Obstetricians and Gynecologists issued its legal position that essentially assigned this novel technology as the universal standard of care [ 49].
